Novartis Phase III data confirm sustained efficacy and long-term safety of oral remibrutinib in chronic spontaneous urticaria
May 30, 2024 18:01 ET
|
Novartis Pharma AG
Patients treated with remibrutinib experienced improvements in weekly urticaria activity scores (UAS7) observed as early as Week 1 and sustained to 1 year (Week 52)1Remibrutinib, an oral Bruton’s...
EPH European Property Holdings PLC announces the Appointment of Christina Spyrou-Katras as Secretary of the Company as well as the Notice for its Annual General Meeting 2024
May 30, 2024 13:00 ET
|
EPH European Property Holdings PLC
30 May 2024, Limassol, Cyprus I Ad hoc announcement pursuant to Art. 53 LR _____________________________________________________________________________________________________________ ...
21.co Launches Wrapped Bitcoin (21BTC) on Solana
May 30, 2024 09:00 ET
|
21Shares
21.co aims to provide simple access to Bitcoin on the Solana blockchain, further enabling deep liquidity on decentralized exchanges, collateral eligibility on lending applications, and...
SIKA ERHÄLT VALIDIERUNG DER SBTi FÜR NETTO-NULL-ZIELE
May 30, 2024 01:00 ET
|
Sika AG
SIKA ERHÄLT VALIDIERUNG DER SBTi FÜR NETTO-NULL-ZIELE Die kurz- und langfristigen Emissionsreduktionsziele, mit denen Sika bis zum Jahr 2050 Netto-null-Emissionen erreicht, wurden von der...
SIKA RECEIVED SBTi VALIDATION FOR ITS NET-ZERO TARGETS
May 30, 2024 01:00 ET
|
Sika AG
SIKA RECEIVED SBTi VALIDATION FOR ITS NET-ZERO TARGETS Sika’s near and long-term emissions reduction targets, aiming for net-zero emissions by 2050, have been validated by the Science Based...
FDA grants Priority Review to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
May 29, 2024 01:00 ET
|
F. Hoffmann-La Roche Ltd
Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options1,2Additional analyses of INAVO120 will be presented in an...
21Shares Lists Four Physically Backed Crypto-Asset ETNs on London Stock Exchange
May 28, 2024 03:15 ET
|
21Shares
London, UK, 28th May 2024 – 21Shares, the world’s largest issuer of crypto exchange-traded products (ETPs), today announced the launch of four physically backed crypto-asset exchange traded notes...
WISeKey begrüßt die Entscheidung der Eidgenossenschaft, bis 2026 eine eigene „Cloud“ einzurichten
May 28, 2024 01:00 ET
|
Wisekey International Holding Ltd.
Genf, Schweiz – 28. Mai 2024: WISeKey International Holding Ltd. („WISeKey“) (SIX: WIHN, NASDAQ: WKEY), ein weltweit führendes Unternehmen im Bereich Cybersicherheit, digitale Identität und Internet...
Santhera veröffentlicht Einladung zur ordentlichen Generalversammlung
May 28, 2024 01:00 ET
|
Santhera Pharmaceuticals Holding AG
Ad-hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 28. Mai 2024 – Santhera Pharmaceuticals (SIX: SANN) hat heute die Einladung zur ordentlichen Generalversammlung (GV) veröffentlicht, die am...
Santhera Publishes Agenda for its Annual General Meeting
May 28, 2024 01:00 ET
|
Santhera Pharmaceuticals Holding AG
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May 28, 2024 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be...